Chemical Structure (Solu Cortef 01)
Solu-cortef Injection, Powder, For Solution
Product Images NDC 0009-0016
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Solu-cortef (NDC 0009-0016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Solu Cortef 02)
Logo (Solu Cortef 03)
This is a label for an injectable medication, distributed by the company Pharmacia & Upjohn Co, which is a division of Pfizer Inc, located in New York.*
Principal Display Panel (100 mg Vial Label)
This is a description for Solu-Cortef, a medication used for intravenous or intramuscular injection purposes. Each vial of the medication contains 100 mg of hydrocortisone in the form of hydrocortisone sodium succinate. The medication should be protected from light and discarded after three days. This product is distributed by Pharmacia & Upjohn Co, a division of Pfizer in NY, NY. More information on dosage and usage can be found in the accompanying prescribing information. The text also includes important identification codes for the medication, such as NDC 0009-0825-01.*
Principal Display Panel (100 mg Vial Carton)
This is a description of a medication called Solu-Cortef. It is a hydrocortisone sodium succinate used for intramuscular or intravenous injections. The recommended adult dosage is 100 mg, dissolved in not more than 2 mL of solution. The medication is stored at a controlled room temperature of 20 to 25°C. It comes in a vial format, and should only be used if the solution is clear. The medication is preserved with dibasic sodium phosphate, anhydrous and is pH balanced with sodium. The medication is lyophilized in a container, and the accompanying prescribing information should be reviewed before use. The lot number, expiration date, and serial number are indicated on the packaging.*
Principal Display Panel (100 mg Single-Dose Vial Label)
Solu-Cortef is a lyophilized container drug available in 2mL Act-0-Vial (NDC 0009-0011-03) dosage form. Each 2mL (when mixed) contains hydrocortisone sodium succinate equivalent to 100mg of hydrocortisone. This drug is distributed by Pharmacia & Upjohn Co and is for IM or IV use only. It is preservative-free and should be protected from light. The prescribing information should be consulted before use. The solution should not be used after 3 days from the time it is prepared.*
Principal Display Panel (100 mg Single-Dose Vial Carton)
Solu-Cortef is a hydrocortisone sodium succinate injection that comes in a 100mg vial for intramuscular or intravenous use. It is preservative-free and should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F). The top of the stopper should be sterilized with a suitable germicide before use. The solution should be discarded if not used within three days.*
Principal Display Panel (250 mg Single-Dose Vial Label)
This text includes information about the Solu-Cortef drug, a hydrocortisone sodium succinate injection designed for intramuscular or intravenous use. Each 2mL vial contains 250mg of hydrocortisone sodium succinate. The drug's packaging specifies that the solution should be protected from light and discarded three days after reconstitution. The drug is distributed by Pharmacia & Upjohn Co, which is a division of Pizer Inc, in New York, NY. The text also provides information about the drug's single-dose vial and its prescribing information.*
Principal Display Panel (250 mg Single-Dose Vial Carton)
This is a description for Solu-Cortef, which is hydrocortisone sodium succinate used for injection (intramuscular or intravenous). It is available in single-dose vials containing 250 mg/vial. The Act-0-Vial system uses an activator to force open the compartment where the vial is located so it can be used. After mixing the liquid, it should be used within three days and stored at room temperature of (68 to T°F). The text includes dosage and use guidelines, but doesn't feature any further information or details.*
Principal Display Panel (500 mg Single-Dose Vial Label)
Solu-Cortef® is a hydrocortisone sodium succinate for injection, intended for intravenous or intramuscular use only. The usual required dosage is 250 mg, and the drug should be stored in a controlled environment between 20°C to 25°C (68°F to 77°F). Once mixed, the Lyophilized drug should be discarded after three days, and it should be protected from light. Pharmacia & Upiohn Co Diision of Pize Inc, NY, WY 10017 distributes it as a single-dose vial, and the vial contains 500mg/vial. However, for more information on dosage and usage, one should refer to the accompanying prescribing information.*
Principal Display Panel (500 mg Single-Dose Vial Carton)
This is a description of a medication named Solu-Cortef. It is a single-dose vial with a capacity of 4 mL. The medication contains hydrocortisone sodium succinate for injection, USP, with a concentration of 500 mg/vial. It can be administered intramuscularly or intravenously. The medication is preservative-free. The dosage, usage, and other necessary information are mentioned in the accompanying instructions. The container is lyophilized, and it has directions for use with the Act-0-Val System on the label. The medication should be stored at controlled room temperature. The imprint area of the vial describes the medication's name and dosage. The vial is distributed by Pharmacia & Upjohn Co, a division of Pfizer, NY.*
Principal Display Panel (1000 mg Single-Dose Vial Label)
This is a description of Solu-Cortef (hydrocortisone sodium succinate for injection, USP), which is a medication that comes in a single-dose vial. Each 8 mL contains 1000 mg of hydrocortisone. It is used for intramuscular or intravenous injections and does not contain a preservative. Directions for use can be found in the accompanying prescribing information. It is distributed by Pharmacia & Upjohn Co and must be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F) and must be protected from light. The solution should be discarded after three days.*
Principal Display Panel (1000 mg Single-Dose Vial Carton)
This is a pharmaceutical product that contains hydrocortisone sodium succinate for injection. It comes in single-dose vials of 8mL Act-0-Vial® Solu-Cortef® with 1000 mg/vial. It is intended for intramuscular or intravenous use and is preservative-free. The solution must be stored in a controlled room temperature of 20° to 25°C (68" to 77°F). The instructions for using the Act-0-Vil® System are also provided. The manufacturer of this product is Pharmacia & Upjohn Co. Division of Pfizer Inc., located in NY, NY.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
